“…In other studies, KAT6B has been shown to acetylate H3K23 in small cell lung cancer cells ( Simo-Riudalbas et al., 2015 ) and K562 and 293T cell lines ( Klein et al., 2019 ), with no effect on H3K9ac or H3K14ac described. KAT7, by comparison, is required for global H3K14ac levels in a variety of cell types ( Kueh et al., 2011 , 2023 ), while KAT6A has been shown to be required for H3K9ac in vivo at specific loci ( Voss et al., 2009 , 2012 ) and H3K23 in glioblastoma cell lines in vitro ( Lv et al., 2017 ). Consistently, we observed a global reduction in H3K23ac in Kat6a +/− fetal liver cells and reduction in both H3K9ac and H3K23ac when both KAT6B and KAT6A were deficient.…”